STEPAN ($SCL) posted quarterly earnings results on Wednesday, October 29th. The company reported earnings of $0.48 per share, missing estimates of $0.62 by $0.14. The company also reported revenue of $590,280,000, missing estimates of $599,586,500 by $-9,306,500.
You can see Quiver Quantitative's $SCL stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
STEPAN Insider Trading Activity
STEPAN insiders have traded $SCL stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $SCL stock by insiders over the last 6 months:
- F QUINN JR STEPAN has made 0 purchases and 2 sales selling 10,000 shares for an estimated $501,569.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
STEPAN Hedge Fund Activity
We have seen 94 institutional investors add shares of STEPAN stock to their portfolio, and 111 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY removed 202,836 shares (-42.7%) from their portfolio in Q2 2025, for an estimated $11,070,788
- NFJ INVESTMENT GROUP, LLC added 158,683 shares (+inf%) to their portfolio in Q2 2025, for an estimated $8,660,918
- NORGES BANK removed 116,622 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $6,365,228
- BRIDGEWAY CAPITAL MANAGEMENT, LLC added 102,105 shares (+inf%) to their portfolio in Q2 2025, for an estimated $5,572,890
- WESTWOOD HOLDINGS GROUP INC added 83,941 shares (+6.7%) to their portfolio in Q2 2025, for an estimated $4,581,499
- CENTERBOOK PARTNERS LP added 81,045 shares (+469.7%) to their portfolio in Q2 2025, for an estimated $4,423,436
- BANK OF NEW YORK MELLON CORP removed 77,685 shares (-24.9%) from their portfolio in Q2 2025, for an estimated $4,240,047
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
